AbbVie Inc. Price Today
AbbVie Inc.
ABBV
Healthcare
$260.64B
💰
Market Cap
34.8
💸
Price to Earnings
$4.2
🎉
EPS
+72
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
15 |
Strong Buy |
5 |
Hold |
16 |
Sell |
0 |
Strong Sell |
0 |
ABBV Price Forecast Target
147.7 👉 195.0 +32%
ABBV EPS Forecast
4.2 👉 11.1 +160%
Financials
Profit Margin
16 %
Revenue Growth
-4.9 %
Dividend
$ 5.92
Held Percent
0.1% - Insiders
71.4% - Institutions
28.5% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $23.7B
-
💰 Blackrock Inc. $20.5B
-
💰 State Street Corporation $11.4B
-
💰 JP Morgan Chase & Company $8.6B
-
💰 Capital International Investors $6.3B
Stock Ideas
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.
David Tepper Portfolio
David Tepper is a renowned billionaire investor, widely known for his incredible success during the 2009 financial crisis where he made a staggering $4 billion. His financial prowess has earned him the distinction of being the 258th richest individ…
Ray Dalio Portfolio
Ray Dalio, a visionary entrepreneur and investment strategist, laid the foundation of Bridgewater with a clear vision in mind. His relentless pursuit of excellence, coupled with an unwavering commitment to innovation, has propelled Bridgewater to be…
Daniel Sundheim Portfolio
Daniel Sundheim is the founder of D1 Capital Partners, a renowned multi-billion dollar global investment firm. Prior to starting his own firm, Sundheim worked as a portfolio manager at prestigious hedge funds before breaking out on his own in 2018. …📮FAQ
Some Frequently Asked Questions.
The AbbVie Inc. industry is Drug Manufacturers—General
The AbbVie Inc. sector is Healthcare
The AbbVie Inc. forecasted predicted Price to Earnings PE ratio is 13.4
The AbbVie Inc. Price to Earnings PE ratio is 34.8
The Market Capitalization of AbbVie Inc. is $260.64B
There are total of 1761519745 float shares with 71.4% held by Institutions and 0.1% held by insiders
The MAbbVie Inc. forecasted Earnings per Share EPS is $11.1
The AbbVie Inc. Earnings per Share EPS is 4.2
The AbbVie Inc. company has $41527000000 gross profits with 16 profit margins
The AbbVie Inc. Earnings Growth is 1.235% with 1.19% quarterly earnings growth
The AbbVie Inc. Revenue is $56022999040 with -0.049 revenue growth
The price target for AbbVie Inc. stock is $195.0 for the high target and $135.0 for the low target
The consensus analyst recommendations for AbbVie Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for AbbVie Inc. is Buy, with the following breakdown:
- Buy: 15
- Strong Buy: 5
- Hold: 16
- Sell: 0
- Strong Sell: 0
The Beta of AbbVie Inc. is 0.5
The dividend of AbbVie Inc. is $5.92
The dividend yield of AbbVie Inc. is 0.0401%
The biggest institutional and mutual fund holders of AbbVie Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
- JP Morgan Chase & Company
The AbbVie Inc. ESG Score is 72, with the following breakdown:
- E: 1.12
- S: 16.77
- G: 9.95